Skip to main content

Table 1 Patient characteristics

From: Biomarker testing in MCI patients—deciding who to test

 

Total

n = 402

Non-progressors

n = 213

Progressors

n = 189

Age

66 ± 8

65 ± 8

67 ± 8

Sex, No. F (%)

164 (41%)

76 (36%)

88 (47%)

MMSE

27 ± 2

27 ± 2

26 ± 3

Follow-up

3 ± 2

3 ± 2

3 ± 2

MRI

 HCV (cm3, sum)

6.8 ± 1

7.1 ± 1

6.5 ± 1

CSF

 Abeta (1-42) pg/ml

778 (652–1083)

976 (732–1191)

686 (596–783)

 t-tau pg/ml

397 (265–626)

291 (207–422)

566 (379–794)

 pTau pg/ml

62 (44–85)

51 (36–69)

76 (59–100)

  1. CSF cerebrospinal fluid, HCV hippocampal volume, MMSE Mini-Mental State Examination, MRI magnetic resonance imaging. CSF was measured with Innotest and Abeta values are drift corrected [29]. Of note: t-tau is not included in the models